An observational trial: Patient profile of users of secomet V®

South African Family Practice

Volumn 52, Issue 2, 2010, Pages 165-

  van Rensburg, C E J ^a   Gandy, J J ^a   Snyman, J R ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; FULVIC ACID; GLUTAMINE; LACTATE DEHYDROGENASE; SECOMET V; SELENIUM; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROLYTE BALANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; QUALITY OF LIFE; QUESTIONNAIRE; VIRUS LOAD;

EID: 77952381722     PISSN: 20786190     EISSN: 20786204     Source Type: Journal    
DOI: 10.1080/20786204.2010.10873964     Document Type: Letter

References (1)

1. Bolognesi N. Bad Medicine. Nature Med 2006;12:723-724.